Omnicell Inc. logo

Omnicell Inc. (OMCL)

Market Open
1 Sep, 18:40
NASDAQ (NGS) NASDAQ (NGS)
$
34. 24
-0.92
-2.6166%
$
1.6B Market Cap
- P/E Ratio
- Div Yield
401,983 Volume
1.07 Eps
$ 35.16
Previous Close
Add Transaction
Day Range
34.07 35.6
Year Range
29.06 55
Want to track OMCL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

OMCL trading today lower at $34.24, a decrease of -2.6166% from yesterday's close, completing a monthly decrease of -3.6307% or -$1.29. Over the past 12 months, OMCL stock lost -24.415%.
OMCL is not paying dividends to its shareholders.
The last earnings report, released on Apr 23, 2026, missed the consensus estimates by -0.2729%. On average, the company has fell short of earnings expectations by -0.0731%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

OMCL Chart

People also search for

BLU
BELLUS Health Inc
$ 14.74
+0.0339%
Immunocore Holdings plc American Depositary Receipt
$ 36.55
+0.6429%
Compass Pathways plc Depositary Receipt
$ 13.22
-2.1466%
Surgery Partners Inc.
$ 14.75
+6.1893%
VNET Group Inc. American Depositary Receipt
$ 6.22
+2.6403%
Why Omnicell (OMCL) is a Top Value Stock for the Long-Term

Why Omnicell (OMCL) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 week ago
Omnicell Raises 2026 EPS Outlook as Memory Costs Pressure Margins

Omnicell Raises 2026 EPS Outlook as Memory Costs Pressure Margins

OMCL raised its 2026 EPS outlook after a strong second quarter, but rising memory-chip costs and delayed hospital purchases could test margins.

Zacks | 2 weeks ago
OMCL Falls 20.1% in a Month as Booking and Margin Risks Build

OMCL Falls 20.1% in a Month as Booking and Margin Risks Build

Omnicell's 20.1% monthly slide reflects booking uncertainty, margin pressure and refresh-cycle risks despite a higher 2026 profit outlook.

Zacks | 2 weeks ago

Omnicell Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
Curtis Ellergodt
Curtis Ellergodt Rothschild Investment LLC
114 $3,888.91 $4,237.38 $348.47 8.96%
JD
Jim Dushek HARBOUR INVESTMENTS Inc.
100 $11,375 $3,686 -$7,689 -67.6%
SN
Stephanie Nee HARBOR CAPITAL ADVISORS Inc.
11,536 $385,071.68 $424,640.16 $39,568.48 10.28%
BG
Bart Gancher Intech Investment Management LLC
52,505 $2.09M $1.93M -$155,071.51 -7.43%
JM
John Malone Amundi
28,275 $1.28M $1.04M -$238,641 -18.63%

Omnicell Inc. (OMCL) FAQ

What is the stock price today?

The current price is $34.24.

On which exchange is it traded?

Omnicell Inc. is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is OMCL.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 1.6B.

Has Omnicell Inc. ever had a stock split?

No, there has never been a stock split.

Omnicell Inc. Profile

Health Care Technology Industry
Healthcare Sector
Randall A. Lipps CEO
NASDAQ (NGS) Exchange
68213N109 CUSIP
US Country
3,485 Employees
- Last Dividend
- Last Split
7 Aug 2001 IPO Date

Overview

Omnicell, Inc., is a prominent entity in the healthcare industry, offering advanced medication management solutions and adherence tools across the United States and beyond. This company has established itself as a crucial partner for healthcare systems and pharmacies by providing a suite of products aimed at enhancing the efficiency and reliability of medication dispensing and management. Founded in 1992 and initially known as Omnicell Technologies, Inc., the company underwent a rebranding to Omnicell, Inc. in 2001. With its headquarters in Fort Worth, Texas, Omnicell continues to innovate and expand its solutions to meet the ever-evolving needs of healthcare providers and patients alike.

Products and Services

  • Point of Care Automation Solutions
  • These solutions are designed to enhance the workflow of clinicians in the patient care areas, significantly improving efficiency and accuracy in medication administration.

  • XT Series Automated Dispensing Systems
  • These systems are used for the secure dispensing of medications and supplies in nursing units and other hospital areas, including the operating room, ensuring controlled access and accurate tracking.

  • Robotic Dispensing Systems
  • These systems automate the stocking and retrieval of boxed medications, optimizing pharmacy operations and enhancing medication safety.

  • Central Pharmacy Automation Solutions
  • Omnicell offers a comprehensive suite of central pharmacy automation solutions that streamline medication inventory and dispensing processes, contributing to more efficient pharmacy operations.

  • IV Compounding Robots
  • These robots automate the preparation of intravenous medications, reducing the risk of contamination and ensuring precise compounding of medications.

  • Inventory Management Software
  • This software solution helps healthcare facilities manage their medication and supply inventory more effectively, reducing waste and ensuring availability of critical items.

  • Single-Dose Automation Solutions
  • Omnicell’s solutions in this category focus on the automated filling and labeling of patient-specific, single-dose medication blister packaging, enhancing the accuracy and efficiency of medication dispensing.

  • Automated and Semi-Automated Filling Equipment
  • Suitable for institutional pharmacies, this equipment streamlines the packaging of medications, supporting both fully automated and semi-automated processes.

  • Medication Blister Card Packaging and Supplies
  • These products support medication adherence in non-acute care settings by providing user-friendly packaging solutions that encourage patients to follow their medication regimens.

  • EnlivenHealth Patient Engagement
  • A web-based solution offered by Omnicell aimed at engaging patients in their medication management to improve adherence and outcomes.

Contact Information

Address: 4220 North Freeway
Phone: 650 251 6100